Published in Liver Transpl on February 01, 2002
Serum sodium, renal function, and survival of patients with end-stage liver disease. J Hepatol (2010) 1.62
Hydroxyethyl starch and acute kidney injury in orthotopic liver transplantation: a single-center retrospective review. Anesth Analg (2015) 1.27
Acute kidney injury after hepatic ischemia and reperfusion injury in mice. Lab Invest (2008) 1.22
Paneth cell-derived interleukin-17A causes multiorgan dysfunction after hepatic ischemia and reperfusion injury. Hepatology (2011) 1.12
Sphinganine-1-phosphate protects kidney and liver after hepatic ischemia and reperfusion in mice through S1P1 receptor activation. Lab Invest (2010) 1.06
Sphinganine-1-phosphate attenuates both hepatic and renal injury induced by hepatic ischemia and reperfusion in mice. Shock (2010) 1.00
Protection against acute kidney injury via A(1) adenosine receptor-mediated Akt activation reduces liver injury after liver ischemia and reperfusion in mice. J Pharmacol Exp Ther (2010) 0.97
Human heat shock protein 27-overexpressing mice are protected against acute kidney injury after hepatic ischemia and reperfusion. Am J Physiol Renal Physiol (2009) 0.91
Global consequences of liver ischemia/reperfusion injury. Oxid Med Cell Longev (2014) 0.90
Updates on Hepato-Renal Syndrome. J Anesth Clin Res (2013) 0.83
Metabolic and cardiovascular complications in the liver transplant recipient. Ann Gastroenterol (2015) 0.82
Renal outcomes of simultaneous liver-kidney transplantation compared to liver transplant alone for candidates with renal dysfunction. Clin Transplant (2014) 0.81
Predictors of renal recovery in patients with pre-orthotopic liver transplant (OLT) renal dysfunction. BMC Nephrol (2013) 0.81
Renal dysfunction in cirrhosis is not just a vasomotor nephropathy. Kidney Int (2014) 0.79
GFR Estimating Equations and Liver Disease. Adv Chronic Kidney Dis (2015) 0.79
The Role of e-NOS in Chronic Cholestasis-Induced Liver and Renal Injury in Rats: The Effect of N-Acetyl Cysteine. Gastroenterol Res Pract (2014) 0.76
Outcomes of liver transplantation in patients with hepatorenal syndrome. World J Hepatol (2016) 0.75
Renal dysfunction in cirrhosis: diagnosis, treatment and prevention. MedGenMed (2004) 0.75
Octreotide Attenuates Acute Kidney Injury after Hepatic Ischemia and Reperfusion by Enhancing Autophagy. Sci Rep (2017) 0.75
Cardiovascular assessment in liver transplant for non-alcoholic steatohepatitis patients: What we do, what we should do. World J Hepatol (2017) 0.75
Sirolimus-associated pulmonary toxicity. Transplantation (2004) 2.15
Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation. Liver Transpl (2009) 1.69
Renal function outcomes following liver transplantation and combined liver-kidney transplantation. Nat Clin Pract Nephrol (2007) 1.52
Preoperative and perioperative predictors of the need for renal replacement therapy after orthotopic liver transplantation. Transplantation (2004) 1.50
Hepatorenal syndrome: pathophysiology and management. Clin J Am Soc Nephrol (2006) 1.50
Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin. Transplantation (2009) 1.47
Results of a prospective randomized trial of sirolimus conversion in kidney transplant recipients on early corticosteroid withdrawal. Transplantation (2011) 1.42
Long-term analysis of combined liver and kidney transplantation at a single center. Arch Surg (2006) 1.36
Thrombendvenectomy for organized portal vein thrombosis at the time of liver transplantation. Ann Surg (2002) 1.24
New onset diabetes mellitus after solid organ transplantation. Endocrinol Metab Clin North Am (2007) 1.19
Noninvasive diagnosis of cellular and antibody-mediated rejection by perforin and granzyme B in renal allografts. Hum Immunol (2006) 1.14
Identification of patients best suited for combined liver-kidney transplantation: part II. Liver Transpl (2002) 1.01
De novo tumors after liver transplantation: a single-institution experience. Liver Transpl (2002) 1.00
Review of major clinical trials with mycophenolate mofetil in renal transplantation. Transplantation (2005) 1.00
Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I study. Transplantation (2003) 1.00
Comparison of kidney function between donation after cardiac death and donation after brain death kidney transplantation. Transplantation (2013) 0.99
Pancreas-kidney and pancreas transplantation for the treatment of diabetes mellitus. Endocrinol Metab Clin North Am (2007) 0.98
Randomized double-blind study of immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with mycophenolate mofetil-containing triple therapy in renal transplantation. Transplantation (2003) 0.97
Development of posttransplant antidonor HLA antibodies is associated with acute humoral rejection and early graft dysfunction. Transplantation (2005) 0.92
Evaluation of the potential living kidney donor. Am J Kidney Dis (2007) 0.90
Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients. Liver Transpl (2002) 0.90
Correlation between intraoperative blood flows and hepatic artery strictures in liver transplantation. Liver Transpl (2002) 0.90
Management of renal dysfunction in the liver transplant recipient. Curr Opin Organ Transplant (2009) 0.88
Inferior long-term outcomes of liver-kidney transplantation using donation after cardiac death donors: single-center and organ procurement and transplantation network analyses. Liver Transpl (2014) 0.85
Changes in the small bowel of symptomatic kidney transplant recipients converted from mycophenolate mofetil to enteric-coated mycophenolate sodium. Am J Nephrol (2014) 0.85
Predictors and risk factors for recurrent scleroderma renal crisis in the kidney allograft: case report and review of the literature. Am J Transplant (2005) 0.82
Inhibitors of ADAMTS13: a potential factor in the cause of thrombotic microangiopathy in a renal allograft recipient. Transplantation (2002) 0.81
ABO blood type-incompatible kidney transplantation and access to organs. Arch Surg (2011) 0.81
Proteinuria following sirolimus conversion is associated with deterioration of kidney function in liver transplant recipients. Transplantation (2012) 0.80
Combined kidney liver transplant in the MELD era: where are we going? Liver Transpl (2005) 0.79
Controversies in combined liver-kidney transplantation: indications and outcomes. Transplant Rev (Orlando) (2008) 0.78
Impact of early conversion from tacrolimus to sirolimus on chronic allograft changes in kidney recipients on rapid steroid withdrawal. Transplantation (2012) 0.77
Hepatorenal syndrome in the intensive care unit. J Intensive Care Med (2011) 0.77
Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med (2003) 0.76
Regional variation in kidney transplant outcomes: trends over time. Clin J Am Soc Nephrol (2008) 0.76
Thrombotic microangiopathy following organ transplantation. Kidney Int (2003) 0.75
Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients. Transplantation (2012) 0.75
Renal outcomes of liver transplant recipients who had pretransplant kidney biopsy. Transplantation (2014) 0.75
Transplantation: impact of pretransplant renal insufficiency. Liver Transpl (2008) 0.75
Validation of a pretransplant risk score for new-onset diabetes after kidney transplantation. Diabetes Care (2013) 0.75
Kidney transplantation at UCLA. Clin Transpl (2002) 0.75
Formal quality improvement curriculum and DMAIC method results in interdisciplinary collaboration and process improvement in renal transplant patients. J Surg Res (2012) 0.75
A novel flow assay for the detection of cytokine secreting alloreactive T cells: application to immune monitoring. Hum Immunol (2006) 0.75
Polymicrobial seminal vesical abscess in a kidney transplant recipient. Urology (2008) 0.75